Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:12 pm Sale |
2024-12-31 | 13G | SEELOS THERAPEUTICS INC PA SEELQ |
Lind Global Fund II LP | 0 0.000% |
-44,500 (Position Closed) |
Filing History |
| 2025-02-14 5:09 pm Purchase |
2024-12-31 | 13G | SEELOS THERAPEUTICS INC PA SEELQ |
JANE STREET GROUP, LLC | 38,349 6.600% |
38,349 (New Position) |
Filing History |
| 2024-12-04 1:29 pm Sale |
2024-11-30 | 13G | SEELOS THERAPEUTICS INC PA SEELQ |
AdvisorShares Trust | 20,543 4.710% |
-131,901 (-86.52%) |
Filing History |
| 2024-11-25 3:37 pm Purchase |
2024-11-14 | 13G | SEELOS THERAPEUTICS INC PA SEELQ |
Weber Mark | 46,480 10.700% |
46,480 (New Position) |
Filing History |
| 2024-11-14 7:32 pm Purchase |
2024-09-30 | 13G | SEELOS THERAPEUTICS INC PA SEELQ |
Lind Global Fund II LP | 44,500 9.900% |
44,500 (New Position) |
Filing History |
| 2024-11-05 1:46 pm Purchase |
2024-10-31 | 13G | SEELOS THERAPEUTICS INC PA SEELQ |
AdvisorShares Trust | 152,444 34.960% |
152,444 (New Position) |
Filing History |
| 2024-02-06 5:26 pm Purchase |
2024-01-30 | 13G | Seelos Therapeutics, Inc. SEEL |
Lind Global Fund II LP | 11,022 9.900% |
11,022 (New Position) |
Filing History |
| 2023-02-09 11:32 am Sale |
2022-12-30 | 13G | Seelos Therapeutics, Inc. SEEL |
The Vanguard Group | 1,306 4.680% |
-34 (-2.52%) |
Filing History |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Seelos Therapeutics, Inc. SEEL |
BLACKROCK INC BLK |
463 1.700% |
-1,246 (-72.88%) |
Filing History |
| 2022-02-10 08:37 am Purchase |
2021-12-31 | 13G | Seelos Therapeutics, Inc. SEEL |
The Vanguard Group | 1,340 5.030% |
611 (+83.81%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Seelos Therapeutics, Inc. SEEL |
BLACKROCK INC BLK |
1,709 6.400% |
1,709 (New Position) |
Filing History |
| 2021-02-10 11:52 am Purchase |
2020-12-31 | 13G | Seelos Therapeutics, Inc. SEEL |
The Vanguard Group | 729 5.240% |
729 (New Position) |
Filing History |
| 2021-01-15 4:11 pm Unchanged |
2020-12-31 | 13G | Seelos Therapeutics, Inc. SEEL |
LIGAND PHARMACEUTICALS INC LGND |
579 4.100% |
0 (Unchanged) |
Filing History |
| 2021-01-11 4:02 pm Sale |
2020-12-31 | 13G | Seelos Therapeutics, Inc. SEEL |
Phoenixus AG | 0 0.000% |
-521 (Position Closed) |
Filing History |